National Facilitators and Barriers to the Implementation of Incentives for Antibiotic Access and Innovation.

ABSTRACT: Prominent reports have assessed the challenges to antibiotic innovation and recommended implementing "pull" incentives, i.e., mechanisms that give increased and predictable revenues for important, marketed antibiotics. We set out to understand countries' perceptions of these recommendations, through frank and anonymous dialogue. In 2019 and 2020, we performed in-depth interviews with national policymakers and antibiotic resistance experts in 13 countries (ten European countries and three non-European) for a total of 73 individuals in 27 separate interviews. Interviewees expressed high-level support for antibiotic incentives in 11 of 13 countries. There is recognition that new economic incentives are needed to maintain a reliable supply to essential antibiotics. However, most countries are

SUBMITTER: Ardal C 

PROVIDER: S-EPMC8234425 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature